Target intelligence / Profile preview

Chymosin pseudogene (CYMP)

Target
CYMP
Molecular classification
Pseudogene
01

Overview

The chymosin pseudogene (CYMP) is a nonfunctional genetic remnant of the gene encoding chymosin (also called rennin), an aspartic protease found in the stomachs of newborn ruminant animals and used commercially in cheese production. The true, functional chymosin (EC 3.4.23.4, 'rennin') is an aspartic protease active in young ruminants. In humans, however, the gene is present but rendered inactive by mutation, meaning no functional chymosin protein is produced. Humans digest milk proteins using other enzymes, such as pepsin and lipase, and the presence of this pseudogene does not serve any current physiological function in the human body. Accordingly, this pseudogene is not considered a therapeutic target nor a functional receptor, enzyme, or protein in humans. The use of "CYMP" as a target in humans is incorrect as it refers to a sequence incapable of producing protein and with no known biological, disease, or therapeutic relevance. There are no drugs, disease associations, mechanisms of action, or biomarkers linked to the human chymosin pseudogene.

Other names
Chymosinrennin pseudogeneCYMP

Beyond the preview

Go deeper on Chymosin pseudogene (CYMP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chymosin pseudogene (CYMP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call